Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.31 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.31 |
| ▸ | GRM5 | P41594 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.30 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25887036 | 0.96 | HIF1A (0.34) | CNR2KDM4ELMNAHTTSMN1; SMN2 | |
| SCHEMBL23176879 | 0.92 | SIRT2 (0.36) | KDM4ELMNAHTTSMN1; SMN2HSP90AA1 | |
| SCHEMBL21743331 | 0.90 | HSP90AA1 (0.35) | KDM4ELMNAHTTSMN1; SMN2HIF1A | |
| SCHEMBL21861168 | 0.84 | MCL1 (0.40) | KDM4ELMNAHTTSMN1; SMN2MCL1 | |
| SCHEMBL19313649 | 0.82 | TRPV1 (0.33) | KDM4ELMNAHTTSMN1; SMN2HSP90AA1 | |
| SCHEMBL21935789 | 0.82 | MAPK1 (0.30) | — | |
| SCHEMBL20169567 | 0.82 | KAT6A (0.35) | CNR1KDM4ELMNAHTTSMN1; SMN2 | |
| SCHEMBL22650171 | 0.77 | KDM4E (0.36) | CNR1KDM4ELMNAHTTSMN1; SMN2 | |
| SCHEMBL23161862 | 0.77 | KDM4E (0.49) | KDM4ELMNAHTTSMN1; SMN2HIF1A | |
| SCHEMBL23161497 | 0.77 | KDM4E (0.49) | KDM4ELMNAHTTSMN1; SMN2HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220393112-A1 | Organic Semiconductor Layer, Organic Electronic Device Comprising the Same and Compounds Therefor | NOVALED GMBH (DE) | 2022-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220393112-A1 | Organic Semiconductor Layer, Organic Electronic Device Comprising the Same and Compounds Therefor | SLC39A11, OR51E2, COMT | CNR2 4669/4885CNR1 4501/4885KDM4E 1381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.